Robert Uger, Chief Scientific Officer at Trillium Therapeutics, holds 0.00 shares in Trillium Therapeutics (Ticker: TRIL). Most recently, Robert Uger ― shares of Trillium Therapeutics on ― for an estimated value of ―.

See the Hottest Stocks Based on Insider Trading >

Robert Uger
Trillium Therapeutics (TRIL)
Chief Scientific Officer

Not Ranked

Robert Uger has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

Robert Uger does not currently own shares as a corporate insider.

A breakdown of Robert Uger's holdings

See the Top Stocks by Insiders

Insider Roles

Robert Uger does not currently hold a role as a corporate insider.

Roles that Robert Uger holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Currently, no data available

The most profitable trade made by Robert Uger

See the Latest Stocks Traded by Insiders

Robert Uger's Trading History

TRIL

Trillium Therapeutics

―

$0.00

TRIL

is no longer traded

Robert Uger has not reported any informative transactions for TRIL, therefore, performance cannot be measured.

List of latest transactions for each holding click on a transaction to see Robert Uger's performance on stock

See All Insider Trading from Today

Robert Uger insider profile FAQ

What is the percentage of profitable transactions made by Robert Uger?

The percentage of profitable transactions made by Robert Uger is ―.

What is the average return per transaction made by Robert Uger?

The average return per transaction made by Robert Uger is ―.

What stocks does Robert Uger hold?

Robert Uger holds: TRIL stocks.

What was Robert Uger’s latest transaction?

Robert Uger latest transaction was an Uninformative Buy of ―.

What was Robert Uger's most profitable transaction?

Robert Uger’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.

What is Robert Uger's role in Trillium Therapeutics?

Robert Uger's role in Trillium Therapeutics is Chief Scientific Officer.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Robert Uger Insider Profile

Robert Uger Trillium Therapeutics (TRIL)Chief Scientific Officer